A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)
Status:
Terminated
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of the combination of rituximab and
prednisone as initial therapy for chronic graft-versus-host disease (C-GVHD).